Recent breakthroughs in biofluid-based biomarkers are fundamentally altering the diagnosis and clinical management of Alzheimer's disease and other neurodegenerative conditions. Advanced technologies now enable the detection of specific proteins, such as amyloid-β, tau, and neurofilament light, in blood and cerebrospinal fluid to reflect ongoing brain pathology. These molecular tools facilitate ea...去小宇宙查看完整单集简介
前往小宇宙评论区与主播互动
前往小宇宙评论区与主播互动
Fler avsnitt av Paper Talk
Visa alla avsnitt av Paper TalkPaper Talk med 淼淼Elva finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
